HR 2213 — Medical Supply Chain Resiliency Act
Congress 119 · introduced 2025-03-18
Latest action: — Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
- Gillen, Laura (D, NY-4) — cosponsor
- Murphy, Gregory F. (R, NC-3) — cosponsor
- Davis, Donald G. (D, NC-1) — cosponsor
- Johnson, Julie (D, TX-32) — cosponsor
- Miller, Carol D. (R, WV-1) — cosponsor
Lobbied by (3)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | — | HR 2213 |
| 1st Quarter - Report | 2026 first_quarter | LMH STRATEGIC SOLUTIONS | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $30,000 | H.R.2213 |
| 1st Quarter - Report | 2026 first_quarter | AMERICA'S ESSENTIAL HOSPITALS | AMERICA'S ESSENTIAL HOSPITALS | — | HR 2213 |
Action timeline
- · H11100 — Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- · H11100 — Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- · Intro-H — Introduced in House
- · 1000 — Introduced in House
Text versions
- Introduced in House · 2025-03-18 — open
Connected on the graph
Inbound (8)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Gillen, Laura | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Davis, Donald G. | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Miller, Carol D. | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Murphy, Gregory F. | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Johnson, Julie | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2026-01-01 | AMERICA'S ESSENTIAL HOSPITALS | lobbies_on_bill | — | HR 2213 | lobbying_bill_mention |
| 2026-01-01 | HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | lobbies_on_bill | — | HR 2213 | lobbying_bill_mention |
| 2026-01-01 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | lobbies_on_bill | — | H.R.2213 | lobbying_bill_mention |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Davis, Donald G. (D, house NC-1) | cosponsor | 3 | — | 4 |
| 2 | Gillen, Laura (D, house NY-4) | cosponsor | 2 | — | 3 |
| 3 | Murphy, Gregory F. (R, house NC-3) | cosponsor | 1 | — | 2 |
| 4 | Johnson, Julie (D, house TX-32) | cosponsor | 0 | — | 1 |
| 5 | Miller, Carol D. (R, house WV-1) | cosponsor | 0 | — | 1 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1 | $30,000 | 0 | $0 | $30,000 |
| 2 | not employed | 0 | $0 | 65 | $24,948 | $24,948 |
| 3 | dragonfly | 0 | $0 | 1 | $7,000 | $7,000 |
| 4 | self-employed | 0 | $0 | 13 | $5,590 | $5,590 |
| 5 | puma springs vineyards | 0 | $0 | 1 | $3,500 | $3,500 |
| 6 | method security | 0 | $0 | 1 | $3,500 | $3,500 |
| 7 | hsk consulting | 0 | $0 | 1 | $3,500 | $3,500 |
| 8 | ward and smith | 0 | $0 | 1 | $3,500 | $3,500 |
| 9 | thorsen french advocacy | 0 | $0 | 2 | $3,000 | $3,000 |
| 10 | retired | 0 | $0 | 9 | $2,942 | $2,942 |
| 11 | united states hispanic business counci | 0 | $0 | 1 | $2,500 | $2,500 |
| 12 | s&f family office | 0 | $0 | 1 | $2,500 | $2,500 |
| 13 | duffy & duffy | 0 | $0 | 1 | $2,500 | $2,500 |
| 14 | carolina breast &oncologic surgery | 0 | $0 | 1 | $2,000 | $2,000 |
| 15 | vista food exchange | 0 | $0 | 1 | $2,000 | $2,000 |
| 16 | schreck rose dapello & adams llp | 0 | $0 | 1 | $2,000 | $2,000 |
| 17 | michael j. fox foundation | 0 | $0 | 1 | $2,000 | $2,000 |
| 18 | healthcare | 0 | $0 | 1 | $2,000 | $2,000 |
| 19 | self employed | 0 | $0 | 6 | $1,700 | $1,700 |
| 20 | liscr | 0 | $0 | 1 | $1,625 | $1,625 |
| 21 | advanced eye mds | 0 | $0 | 1 | $1,625 | $1,625 |
| 22 | clyde duneier | 0 | $0 | 1 | $1,000 | $1,000 |
| 23 | gulf coast bag, inc. | 0 | $0 | 1 | $1,000 | $1,000 |
| 24 | pinnacle facility engineering | 0 | $0 | 1 | $1,000 | $1,000 |
| 25 | cerity partners | 0 | $0 | 1 | $1,000 | $1,000 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
5 predicted yes (1%) · 3 predicted no (1%) · 535 unknown (98%)
By party: · R: 2 yes / 0 no / 275 unknown · D: 3 yes / 0 no / 260 unknown · I: 0 yes / 3 no
5 high-confidence positions (voted + sponsor + cosponsor)
- Davis, Donald G. (D · house · NC-1) · cosponsor
- Gillen, Laura (D · house · NY-4) · cosponsor
- Johnson, Julie (D · house · TX-32) · cosponsor
- Miller, Carol D. (R · house · WV-1) · cosponsor
- Murphy, Gregory F. (R · house · NC-3) · cosponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-17 · cosponsored by Gillen, Laura (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Johnson, Julie (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Murphy, Gregory F. (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Miller, Carol D. (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Davis, Donald G. (cosponsor) · sponsorship
- 2026-01-01 · lobbied on by HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION (hr 2213) · lobbying_bill_mention
- 2026-01-01 · lobbied on by AMERICA'S ESSENTIAL HOSPITALS (hr 2213) · lobbying_bill_mention
- 2026-01-01 · lobbied on by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (h.r.2213) · lobbying_bill_mention